2-201381184-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015049.3(TRAK2):c.2104G>A(p.Gly702Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000471 in 1,612,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015049.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRAK2 | NM_015049.3 | c.2104G>A | p.Gly702Ser | missense_variant | 16/16 | ENST00000332624.8 | |
TRAK2 | XM_047445578.1 | c.2104G>A | p.Gly702Ser | missense_variant | 16/16 | ||
TRAK2 | XM_047445579.1 | c.1471G>A | p.Gly491Ser | missense_variant | 13/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRAK2 | ENST00000332624.8 | c.2104G>A | p.Gly702Ser | missense_variant | 16/16 | 1 | NM_015049.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000530 AC: 8AN: 150836Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000116 AC: 29AN: 249074Hom.: 0 AF XY: 0.0000964 AC XY: 13AN XY: 134842
GnomAD4 exome AF: 0.0000465 AC: 68AN: 1461188Hom.: 0 Cov.: 38 AF XY: 0.0000482 AC XY: 35AN XY: 726788
GnomAD4 genome AF: 0.0000530 AC: 8AN: 150952Hom.: 0 Cov.: 32 AF XY: 0.0000543 AC XY: 4AN XY: 73664
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2023 | The c.2104G>A (p.G702S) alteration is located in exon 16 (coding exon 15) of the TRAK2 gene. This alteration results from a G to A substitution at nucleotide position 2104, causing the glycine (G) at amino acid position 702 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at